Cited 0 times in 
Cited 0 times in 
VALIANT: Randomized, multicenter, double-blind, placebo-controlled, phase 3 trial of pegcetacoplan for patients with native or post-transplant recurrent C3G or primary (idiopathic) IC-MPGN
https://orcid.org/0000-0001-7923-5635Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.